(IBN) ICICI Bank - Overview
Stock: Deposits, Loans, Cards, Insurance, Investments
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.76% |
| Yield on Cost 5y | 1.52% |
| Yield CAGR 5y | 50.92% |
| Payout Consistency | 84.1% |
| Payout Ratio | 12.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.8% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.12 |
| Alpha | -3.46 |
| Character TTM | |
|---|---|
| Beta | 0.276 |
| Beta Downside | 0.269 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.62% |
| CAGR/Max DD | 0.92 |
Description: IBN ICICI Bank January 28, 2026
ICICI Bank Limited (NYSE:IBN) is a diversified Indian financial institution that serves retail and corporate clients through a wide array of segments, including Retail Banking, Wholesale Banking, Treasury, Life and General Insurance, and ancillary services such as wealth management, merchant banking, and fintech-enabled payment solutions. Its product suite spans deposit accounts, consumer and SME loans, trade finance, card services, mutual funds, IPO subscriptions, and a full suite of insurance offerings, positioning the bank as a one-stop financial services provider in India and select overseas markets.
As of the most recent quarter (Q3 FY 2024, ended December 2023), ICICI reported a net profit of **₹ 33.1 billion**, a **13% year-over-year increase**, driven by a **9% growth in the loan book** to ₹ 14.2 trillion and an improvement in the **net interest margin (NIM) to 4.1%**. The bank’s **CASA (current account-saving account) ratio rose to 48.5%**, supporting lower funding costs, while **gross non-performing assets (NPAs) fell to 1.1%**, reflecting tighter credit underwriting amid a backdrop of **India’s FY 2024 GDP growth of ~6.8%** and a relatively stable RBI policy repo rate of 6.5%. These fundamentals suggest the bank is benefiting from strong credit demand in both consumer and SME segments, while macro-economic tailwinds such as rising disposable incomes and continued financial inclusion initiatives bolster its growth outlook.
For a deeper quantitative assessment, you may want to explore the bank’s valuation metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 530.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.35 > 0.02 and ΔFCF/TA 29.26 > 1.0 |
| NWC/Revenue: -1.53% < 20% (prev -490.1%; Δ 488.6% < -1%) |
| CFO/TA 0.48 > 3% & CFO 1054.44b > Net Income 530.59b |
| Net Debt (-34.00b) to EBITDA (1014.28b): -0.03 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.63b) vs 12m ago 1.14% < -2% |
| Gross Margin: 68.65% > 18% (prev 0.68%; Δ 6797 % > 0.5%) |
| Asset Turnover: 22.39% > 50% (prev 11.11%; Δ 11.28% > 0%) |
| Interest Coverage Ratio: 0.94 > 6 (EBITDA TTM 1014.28b / Interest Expense TTM 902.10b) |
Altman Z'' 2.86
| A: -0.02 (Total Current Assets 1612.49b - Total Current Liabilities 1659.61b) / Total Assets 2190.59b |
| B: 0.15 (Retained Earnings 319.20b / Total Assets 2190.59b) |
| C: 0.06 (EBIT TTM 843.79b / Avg Total Assets 13752.73b) |
| D: 2.02 (Book Value of Equity 3766.98b / Total Liabilities 1867.46b) |
| Altman-Z'' Score: 2.86 = A |
Beneish M -2.91
| DSRI: 1.89 (Receivables 1466.15b/709.34b, Revenue 3079.60b/2813.02b) |
| GMI: 0.99 (GM 68.65% / 67.88%) |
| AQI: 0.28 (AQ_t 0.26 / AQ_t-1 0.93) |
| SGI: 1.09 (Revenue 3079.60b / 2813.02b) |
| TATA: -0.24 (NI 530.59b - CFO 1054.44b) / TA 2190.59b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of IBN shares?
Over the past week, the price has changed by +2.09%, over one month by -0.20%, over three months by -4.03% and over the past year by +4.73%.
Is IBN a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IBN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.1 | 31.4% |
| Analysts Target Price | 39.1 | 31.4% |
| ValueRay Target Price | 33.2 | 11.5% |
IBN Fundamental Data Overview January 27, 2026
P/E Trailing = 18.2188
P/E Forward = 16.5289
P/S = 0.0542
P/B = 2.7368
Revenue TTM = 3079.60b INR
EBIT TTM = 843.79b INR
EBITDA TTM = 1014.28b INR
Long Term Debt = 2154.36b INR (from longTermDebt, last quarter)
Short Term Debt = 226.22b INR (from shortTermDebt, last fiscal year)
Debt = 112.33b INR (from shortLongTermDebtTotal, last quarter)
Net Debt = -34.00b INR (from netDebt column, last quarter)
Enterprise Value = 9553.98b INR (9587.98b + Debt 112.33b - CCE 146.34b)
Interest Coverage Ratio = 0.94 (Ebit TTM 843.79b / Interest Expense TTM 902.10b)
EV/FCF = 12.34x (Enterprise Value 9553.98b / FCF TTM 773.94b)
FCF Yield = 8.10% (FCF TTM 773.94b / Enterprise Value 9553.98b)
FCF Margin = 25.13% (FCF TTM 773.94b / Revenue TTM 3079.60b)
Net Margin = 17.23% (Net Income TTM 530.59b / Revenue TTM 3079.60b)
Gross Margin = 68.65% ((Revenue TTM 3079.60b - Cost of Revenue TTM 965.51b) / Revenue TTM)
Gross Margin QoQ = 68.09% (prev 69.89%)
Tobins Q-Ratio = 4.36 (Enterprise Value 9553.98b / Total Assets 2190.59b)
Interest Expense / Debt = 196.3% (Interest Expense 220.56b / Debt 112.33b)
Taxrate = 24.36% (43.79b / 179.72b)
NOPAT = 638.21b (EBIT 843.79b * (1 - 24.36%))
Current Ratio = 0.97 (Total Current Assets 1612.49b / Total Current Liabilities 1659.61b)
Debt / Equity = 0.35 (Debt 112.33b / totalStockholderEquity, last quarter 323.13b)
Debt / EBITDA = -0.03 (Net Debt -34.00b / EBITDA 1014.28b)
Debt / FCF = -0.04 (Net Debt -34.00b / FCF TTM 773.94b)
Total Stockholder Equity = 2528.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 530.59b / Total Assets 2190.59b)
RoE = 20.98% (Net Income TTM 530.59b / Total Stockholder Equity 2528.47b)
RoCE = 18.02% (EBIT 843.79b / Capital Employed (Equity 2528.47b + L.T.Debt 2154.36b))
RoIC = 11.64% (NOPAT 638.21b / Invested Capital 5481.32b)
WACC = 6.85% (E(9587.98b)/V(9700.31b) * Re(6.93%) + (debt cost/tax rate unavailable))
Discount Rate = 6.93% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.75%
[DCF Debug] Terminal Value 75.78% ; FCFF base≈1078.79b ; Y1≈708.16b ; Y5≈323.11b
Fair Price DCF = 2240 (EV 7975.48b - Net Debt -34.00b = Equity 8009.48b / Shares 3.58b; r=6.85% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 82.27 | EPS CAGR: 4.68% | SUE: -1.63 | # QB: 0
Revenue Correlation: 93.95 | Revenue CAGR: 26.39% | SUE: 0.66 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.43 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2027-03-31): EPS=1.78 | Chg30d=-0.033 | Revisions Net=-1 | Growth EPS=+16.7% | Growth Revenue=+13.9%